Aging Population And Robotics Will Elevate Orthopedic Care

Published
08 Aug 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$110.92
6.9% undervalued intrinsic discount
14 Aug
US$103.22
Loading
1Y
-5.0%
7D
13.2%

Author's Valuation

US$110.9

6.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 11%

Shared on30 Apr 25
Fair value Increased 15%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 12%

Shared on16 Apr 25
Fair value Increased 0.065%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 0.19%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.04%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 9.47%

AnalystConsensusTarget has decreased revenue growth from 4.4% to 3.7%.